
Rebiglo L 75mg/20mg Capsule SR
Marketer
PGI Pharmaceuticals
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Rebiglo L 75mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication Rebiglo L 75mg/20mg Sustained-Release Capsules. This medication lowers excessive stomach acid and prevents its backflow into the esophagus. Dosage and duration for Rebiglo L 75mg/20mg SR Capsules are determined by your physician and should be taken with or without food as directed. Treatment should continue as prescribed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and influenza-like symptoms, most of which are transient. Report any concerning side effects immediately to your doctor. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. Lifestyle changes, such as a high-fiber diet, avoidance of trigger foods, increased fluid intake, and regular exercise, can improve outcomes. Prior to commencing treatment, inform your doctor of any kidney or liver conditions, and if you are pregnant, planning pregnancy, or breastfeeding.
Uses of Rebiglo L 75mg/20mg Capsule SR
Managing gastroesophageal reflux disease (GERD), intestinal ulcers, and irritable bowel syndrome.
Major Benefits of Rebiglo L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rebiglo L 75mg/20mg SR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Rebiglo L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Rebiglo L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rebiglo L 75mg/20mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Rebiglo L 75mg/20mg Capsule SR works:
Levosulpiride and rabeprazole, each 75mg and 20mg respectively, are formulated together in Rebiglo L SR capsules.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rebiglo L 75mg/20mg SR capsules with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Rebiglo L 75mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Rebiglo L 75mg/20mg SR Capsule use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Rebiglo L 75mg/20mg sustained-release capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Rebiglo L 75mg/20mg Capsule SR use in individuals with renal impairment. Medical advice is recommended. Preliminary findings, however, indicate that this medication should be administered to such patients with caution.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Rebiglo L 75mg/20mg sustained-release capsules. Dosage modification of Rebiglo L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Rebiglo L 75mg/20mg Capsule SR :
Should you forget a Rebiglo L 75mg/20mg Capsule SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebiglo L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
